Related Experiment Video
Updated: Mar 31, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Glucose Fluctuations Aggravate Cardiac Susceptibility to Ischemia/Reperfusion Injury by Modulating MicroRNAs
Shotaro Saito1, Luong Cong Thuc, Yasushi Teshima
1Department of Cardiology and Clinical Examination, Faculty of Medicine, Oita University.
Background:
The influence of glucose fluctuations (GF) on cardiovascular complications of diabetes mellitus (DM) has been attracting much attention. In the present study, whether GF increase susceptibility to ischemia/reperfusion in the heart was investigated.
Methods And Results:
Male rats were randomly assigned to either a control, DM, and DM with GF group. DM was induced by an injection of streptozotocin, and glucose fluctuation was induced by starvation and insulin injection. One sequential program comprised 2 hypoglycemic episodes during 4 days. The isolated hearts were subjected to 20-min ischemia/30-min reperfusion. The infarct size was larger in hearts with GF than those with sustained hyperglycemia. Activities of catalase and superoxide dismutase were decreased, and expressions of NADPH oxidase and thioredoxin-interacting protein were upregulated by GF accompanied by an increase of reactive oxygen species (ROS). Swollen mitochondria with destroyed cristae were observed in diabetic hearts; they were further devastated by GF. Microarray analysis revealed that the expressions of microRNA (miRNA)-200c and miRNA-141 were abundant in those hearts with GF. Overexpression of miRNA-200c and miRNA-141 decreased mitochondrial superoxide dismutase and catalase activities, and increased ROS levels. Meanwhile, knockdown of miRNA-200c and miRNA-141 significantly decreased ROS levels in cardiomyocytes exposed to GF.
Conclusions:
GF increased ROS generation and enhanced ischemia/reperfusion injury in the diabetic heart. Upregulated miRNA-200c and miRNA-141 may account for the increased ROS.
Insights
Glucose fluctuations (GF) worsen heart damage from ischemia/reperfusion in diabetes mellitus (DM) by increasing reactive oxygen species (ROS). Upregulated microRNAs (miRNAs) 200c and 141 contribute to this heightened oxidative stress.
Area of Science:
- Cardiovascular Research
- Metabolic Disorders
- Molecular Biology
Background:
- Diabetes mellitus (DM) is associated with cardiovascular complications.
- The impact of glucose fluctuations (GF) on these complications is under investigation.
- This study examines if GF exacerbate cardiac ischemia/reperfusion (I/R) injury.
Purpose of the Study:
- To investigate the effect of GF on myocardial susceptibility to ischemia/reperfusion injury in a diabetic rat model.
- To elucidate the underlying mechanisms, including oxidative stress and microRNA involvement.
Main Methods:
- Male rats were divided into control, DM, and DM with GF groups.
- Diabetes was induced by streptozotocin; GF was induced by starvation and insulin.
- Isolated hearts underwent 20-min ischemia/30-min reperfusion; infarct size and biochemical markers were assessed.
Main Results:
- Hearts with GF exhibited larger infarct sizes compared to sustained hyperglycemia.
- GF increased reactive oxygen species (ROS) production and decreased antioxidant enzyme activity.
- Mitochondrial damage was more severe in GF hearts; miRNA-200c and miRNA-141 were upregulated.
- Overexpression of these miRNAs mimicked GF effects, while knockdown reduced ROS.
Conclusions:
- Glucose fluctuations significantly enhance ischemia/reperfusion injury in the diabetic heart.
- Increased ROS generation is a key mediator of this enhanced injury.
- Upregulation of miRNA-200c and miRNA-141 is implicated in the elevated ROS levels observed in GF conditions.
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
